Ex­clu­sive: Ko­mo­do is bet­ting that its newest tool can up­end how health­care da­ta are an­a­lyzed and used

19 minutes ago
Health Tech

Ex­clu­sive: CellFE rais­es $22M Se­ries A to ad­vance a new cell ther­a­py man­u­fac­tur­ing idea

19 minutes ago
Financing
Cell/Gene Tx

Galec­to lays off 70% of staff, con­sid­ers strate­gic al­ter­na­tives af­ter IPF tri­al fail

38 minutes ago
People

Ava­lyn rais­es $175M to test in­haler ver­sions of IPF med­i­cines in PhII tri­als

49 minutes ago
Financing

Ex­clu­sive: Pfiz­er, Gink­go sign R&D deal worth up to $331M to de­vel­op RNA drugs

1 hour ago
Deals
R&D

Force­field Ther­a­peu­tics to start £35M Se­ries A in Oc­to­ber af­ter scoop­ing ex-No­var­tis ex­ec John Tsai as new CEO

2 hours ago
People
Financing

Ab­b­Vie drops Cari­bou part­ner­ship on gene-edit­ed CAR-T ther­a­py

14 hours ago
R&D
Cell/Gene Tx

San­doz, Pol­phar­ma score Eu­ro­pean ap­proval for first Tysabri biosim­i­lar for mul­ti­ple scle­ro­sis

15 hours ago
Pharma
FDA+

J&J shines spot­light on can­cer spe­cial­ty pro­fes­sion in new aware­ness and sup­port ef­fort

16 hours ago
Pharma
Marketing

J&J, IBM named in pro­posed class ac­tion law­suit fol­low­ing da­ta breach

16 hours ago
Pharma
Law

Cost-ef­fec­tive­ness of Mer­ck’s po­ten­tial hy­per­ten­sion drug will hinge on long-term da­ta, ICER says

17 hours ago
R&D
Pharma

How Tik­Tok’s al­go­rithm and au­di­ences are fi­nal­ly con­vinc­ing Big Phar­ma to join

18 hours ago
Pharma
Marketing

Mar­ket­ingRx roundup: Phar­ma in­dus­try rep drops in Gallup poll; Pfiz­er web­site re­veals not-yet-ap­proved drug name

18 hours ago
Pharma
Marketing

Ready for it? Pfiz­er taps Kansas City Chiefs star Travis Kelce for lat­est Covid boost­er cam­paign

18 hours ago
Pharma
Marketing

Bris­tol My­ers joins As­traZeneca in agree­ing to drug price ne­go­ti­a­tion terms ahead of first dead­line

18 hours ago
Law

No­vo Nordisk forms car­diometa­bol­ic drug dis­cov­ery ac­cel­er­a­tor to get to re­search faster

19 hours ago
R&D
Pharma

Pli­ant shares spike on ex­plorato­ry study re­sults of lead drug in chron­ic liv­er dis­ease

20 hours ago
R&D

Pak­istan re­calls al­tered dose of Avastin; FDA re­jects Botanix gel

20 hours ago
News Briefing

Ex­clu­sive: Deep­Mind’s Demis Has­s­abis un­veils his vi­sion for Iso­mor­phic and AI’s fu­ture in biotech

20 hours ago
People
AI

In­ter­cept to sell in $800M cash buy­out af­ter sec­ond NASH re­jec­tion sank hopes

21 hours ago
Deals

Pox­el takes write­down on NASH drug as it con­tin­ues lay­offs, search for cash

Yesterday
People
Pharma

Io­n­is plans NDA fil­ing for first in­de­pen­dent drug af­ter pos­i­tive da­ta read­out in rare ge­net­ic dis­or­der

Yesterday
R&D

Omega Ther­a­peu­tic­s' epige­nom­ic med­i­cines re­duce MYC ex­pres­sion by 55% in ear­ly study of can­cer pa­tients

Yesterday
R&D

De­spite a sum­mer of block­buster rounds, biotech fund­ing is on track to lev­el off at pre-pan­dem­ic norms

Yesterday
Financing
Startups
1234 Next page Last page
A service from the Financial Times